PMID- 25977069 OWN - NLM STAT- MEDLINE DCOM- 20160526 LR - 20150803 IS - 1873-2933 (Electronic) IS - 0009-9120 (Linking) VI - 48 IP - 12 DP - 2015 Aug TI - GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status. PG - 811-4 LID - S0009-9120(15)00169-1 [pii] LID - 10.1016/j.clinbiochem.2015.05.001 [doi] AB - OBJECTIVES: Plasma GlycA is a recently developed biomarker whose nuclear magnetic resonance signal originates from glycosylated acute-phase proteins. The aim of our study was to determine potential relationships between GlycA and adiposity, insulin resistance (HOMA(ir)), high sensitive C-reactive protein (hs-CRP), leptin, adiponectin, and the leptin/adiponectin ratio, and to test whether GlycA is elevated in subjects with impaired fasting glucose (IFG) and type 2 diabetes mellitus (T2DM). DESIGN AND METHODS: Plasma GlycA, hs-CRP, leptin, adiponectin, the leptin/adiponectin ratio, and insulin resistance (HOMA(ir)) were measured in 103 fasting subjects (30 with normal fasting glucose, 25 with IFG and 48 with T2DM). RESULTS: In all subjects combined, plasma GlycA was correlated positively with body mass index (BMI), HOMA(ir), hs-CRP, leptin and the leptin/adiponectin ratio, and inversely with adiponectin (p < 0.05 to p < 0.001). GlycA did not significantly vary according to glucose tolerance category (p = 0.060). GlycA was related positively to the leptin/adiponectin ratio (p = 0.049), independent of BMI (p = 0.056) and HOMA(ir) (p = 0.50). CONCLUSIONS: High plasma GlycA reflects a pro-inflammatory state. Adipose tissue-associated inflammatory processes could contribute to increased circulating levels of glycosylated acute-phase proteins. CI - Copyright (c) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. FAU - Dullaart, Robin P F AU - Dullaart RP AD - Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: r.p.f.dullaart@int.umcg.nl. FAU - Gruppen, Eke G AU - Gruppen EG AD - Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. FAU - Connelly, Margery A AU - Connelly MA AD - LabCorp, Raleigh, NC, USA. FAU - Otvos, James D AU - Otvos JD AD - LabCorp, Raleigh, NC, USA. FAU - Lefrandt, Joop D AU - Lefrandt JD AD - Department of Vascular Medicine, University of Groningen, University Medical Center Groningen, The Netherlands. LA - eng PT - Journal Article DEP - 20150511 PL - United States TA - Clin Biochem JT - Clinical biochemistry JID - 0133660 RN - 0 (Adiponectin) RN - 0 (Biomarkers) RN - 0 (Blood Glucose) RN - 0 (Glycoproteins) RN - 0 (Leptin) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Adiponectin/*blood MH - Biomarkers/blood MH - Blood Glucose/*metabolism MH - C-Reactive Protein/metabolism MH - Case-Control Studies MH - Diabetes Mellitus, Type 2/*blood MH - Female MH - Glycoproteins/*blood MH - Glycosylation MH - Humans MH - Inflammation/blood MH - Leptin/*blood MH - Linear Models MH - Male MH - Middle Aged MH - Nuclear Magnetic Resonance, Biomolecular OTO - NOTNLM OT - C-reactive protein OT - Diabetes mellitus OT - Glycoproteins OT - Leptin/adiponectin ratio OT - Nuclear magnetic resonance spectroscopy EDAT- 2015/05/16 06:00 MHDA- 2016/05/27 06:00 CRDT- 2015/05/16 06:00 PHST- 2015/03/27 00:00 [received] PHST- 2015/05/01 00:00 [revised] PHST- 2015/05/02 00:00 [accepted] PHST- 2015/05/16 06:00 [entrez] PHST- 2015/05/16 06:00 [pubmed] PHST- 2016/05/27 06:00 [medline] AID - S0009-9120(15)00169-1 [pii] AID - 10.1016/j.clinbiochem.2015.05.001 [doi] PST - ppublish SO - Clin Biochem. 2015 Aug;48(12):811-4. doi: 10.1016/j.clinbiochem.2015.05.001. Epub 2015 May 11.